Form 4: Chimerix Director Fred A. Middleton Transfers Shares to Irrevocable Trust

Director Fred A. Middleton reports a transfer of 60,000 Chimerix shares to an irrevocable trust for no consideration, while also disclosing beneficial ownership through various Sanderling Venture Partners entities.

Summary

• On October 28, 2024, Fred A. Middleton, a director of Chimerix, Inc., transferred 60,000 shares of Chimerix common stock to the Middleton Childrens 2015 Irrevocable Trust.
• The transfer was made for no consideration.
• Middleton is the trustee of the trust, and his immediate family members are the beneficiaries.
• Middleton remains the beneficial owner of the securities held by the trust.
• Middleton also has beneficial ownership through various Sanderling Venture Partners entities, including Sanderling Venture Partners V, L.P., and Sanderling Venture Partners VI Co-Investment Fund, L.P.
• He disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein.
• Following the transaction, Middleton directly owns 207,523 shares and indirectly owns a total of 3,307,954 shares through various trusts and partnerships.

Sentiment

Score: 5

Explanation: The document is a standard regulatory filing detailing a share transfer. It doesn't inherently convey positive or negative sentiment.

Industry Context

Form 4 filings are standard practice for reporting changes in beneficial ownership by company insiders, providing transparency to investors.

Related Party Transactions

• The transfer of shares to the Middleton Childrens 2015 Irrevocable Trust, where Fred A. Middleton is the trustee and his family members are beneficiaries, constitutes a related party transaction.

Stakeholder Impact

• The share transfer itself is unlikely to have a significant impact on stakeholders.
• Disclosure of beneficial ownership provides transparency to shareholders.

Key Dates